FDA Inspection 884574 — Dhaliwal Labs South LLC

Dhaliwal Labs South LLC — FEI 3007410731

The FDA completed an inspection of Dhaliwal Labs South LLC on Jun 20, 2014 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 20, 2014
Fiscal Year
2014
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Dallas, TX (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
194321 CFR 211.180(e)(1)Review of representative number of batches
200921 CFR 211.188Prepared for each batch, include complete information

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.